BR0008261A - Processo para preparação de ácido (2r)-propiloctanóico - Google Patents

Processo para preparação de ácido (2r)-propiloctanóico

Info

Publication number
BR0008261A
BR0008261A BR0008261-9A BR0008261A BR0008261A BR 0008261 A BR0008261 A BR 0008261A BR 0008261 A BR0008261 A BR 0008261A BR 0008261 A BR0008261 A BR 0008261A
Authority
BR
Brazil
Prior art keywords
acid
preparation
propyloctanoic acid
propyloctanoic
octanoic
Prior art date
Application number
BR0008261-9A
Other languages
English (en)
Inventor
Norikazu Toda
Kaoru Yamaguchi
Youichi Iguchi
Original Assignee
Ono Pharmaceutical Co
Tokyo Kasei Kogyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ono Pharmaceutical Co, Tokyo Kasei Kogyo Co Ltd filed Critical Ono Pharmaceutical Co
Publication of BR0008261A publication Critical patent/BR0008261A/pt

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J23/00Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00
    • B01J23/38Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals
    • B01J23/40Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals of the platinum group metals
    • B01J23/42Platinum
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J21/00Catalysts comprising the elements, oxides, or hydroxides of magnesium, boron, aluminium, carbon, silicon, titanium, zirconium, or hafnium
    • B01J21/18Carbon
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/347Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups
    • C07C51/36Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups by hydrogenation of carbon-to-carbon unsaturated bonds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Materials Engineering (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Catalysts (AREA)

Abstract

Patente de Invenção: "PROCESSO PARA PREPARAçãO DE áCIDO (2R)-PROPILOCTANóICO". Trata-se de um processo para preparar ácido (2R)-2-propiloctanóico caracterizado por submissão do ácido (2S)-2-(2-propinil)octanóico ou ácido (2S)-2-(2-propenil)octanóico à redução usando platina em carbono. Este processo confere ácido (2R)-2-propiloctanóico com alto grau de pureza óptica sem recorrer à isomerização.
BR0008261-9A 1999-02-18 2000-02-17 Processo para preparação de ácido (2r)-propiloctanóico BR0008261A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP3975899 1999-02-18
PCT/JP2000/000900 WO2000048982A1 (fr) 1999-02-18 2000-02-17 Procede de preparation d'acide (2r)-2-propyloctanoique

Publications (1)

Publication Number Publication Date
BR0008261A true BR0008261A (pt) 2002-01-15

Family

ID=12561862

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0008261-9A BR0008261A (pt) 1999-02-18 2000-02-17 Processo para preparação de ácido (2r)-propiloctanóico

Country Status (19)

Country Link
US (1) US6608221B1 (pt)
EP (3) EP1721882A1 (pt)
JP (2) JP4752989B2 (pt)
KR (1) KR100666423B1 (pt)
CN (4) CN1183082C (pt)
AT (1) ATE359256T1 (pt)
AU (1) AU776927B2 (pt)
BR (1) BR0008261A (pt)
CA (1) CA2364308C (pt)
DE (1) DE60034316T2 (pt)
ES (1) ES2283287T3 (pt)
HU (1) HUP0200358A3 (pt)
MX (1) MXPA01008241A (pt)
NO (1) NO20013971L (pt)
NZ (1) NZ513569A (pt)
RU (1) RU2297406C2 (pt)
TW (1) TWI268921B (pt)
WO (1) WO2000048982A1 (pt)
ZA (1) ZA200106500B (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI268921B (en) * 1999-02-18 2006-12-21 Ono Pharmaceutical Co A process for preparing (2R)-2-propyloctanoic acid
EP1415668A4 (en) 2001-07-18 2007-08-29 Ono Pharmaceutical Co REMEDIES AGAINST BRAIN ISCHEMIC DISEASES
JP2005298334A (ja) * 2001-12-19 2005-10-27 Ono Pharmaceut Co Ltd 新規な中間体化合物およびそれを用いる化合物の製造方法
CN1889941A (zh) * 2003-10-03 2007-01-03 小野药品工业株式会社 包含(2r)-2-丙基辛酸作为活性成分的输液制剂
US7928143B2 (en) * 2003-10-03 2011-04-19 Ono Pharmaceutical Co., Ltd. Method for preventing and/or treating neurodegenerative diseases
BRPI0415001A (pt) * 2003-10-03 2006-11-07 Ono Pharmaceutical Co droga contendo ácido (2r)-2-propiloctanóico como o ingrediente ativo
US7820715B2 (en) 2004-04-28 2010-10-26 Ono Pharmaceutical Co., Ltd. Crystal comprising (2R)-2-propyloctanoic acid and amine
KR20070085379A (ko) * 2004-11-16 2007-08-27 머크 앤드 캄파니 인코포레이티드 뇌졸중 치료용 (2r)-2-프로필옥탄산의 프로드럭
JPWO2006075596A1 (ja) * 2005-01-13 2008-06-12 株式会社クラレ 2−アリルカルボン酸化合物の製造方法
EP2266559A1 (en) 2005-03-15 2010-12-29 Ono Pharmaceutical Co., Ltd. Therapeutic agent for ophthalmic disease
WO2007000970A1 (ja) 2005-06-27 2007-01-04 Ono Pharmaceutical Co., Ltd. 疼痛治療剤
EP1938814A4 (en) 2005-10-18 2009-06-03 Ono Pharmaceutical Co PHARMACEUTICAL PRODUCT FOR PROTECTING MOTOR NERVE IN PATIENTS WITH AMYOTROPHIC LATERAL SCLEROSIS
US20090203783A1 (en) 2005-12-22 2009-08-13 Ono Pharmaceutical Co., Ltd. Therapeutic agent for acute cerebral infarct
WO2007094404A1 (ja) * 2006-02-16 2007-08-23 Sumitomo Chemical Company, Limited 光学活性カルボン酸化合物の製造方法
EP2015741A4 (en) * 2006-05-04 2009-12-23 Merck & Co Inc HISTONE DESACETYLASE INHIBITORS FOR THE TREATMENT OF NEURODEGENERATION
CN102417445B (zh) * 2011-11-05 2013-11-13 中国科学院山西煤炭化学研究所 一种由马来酸合成丁二酸的方法
CN102675166B (zh) * 2012-05-11 2014-03-26 山东齐都药业有限公司 用于制备2-丙基庚酸的新中间体、其制备方法及2-丙基庚酸的制备方法
CN102786407B (zh) * 2012-08-15 2014-04-16 湖北大学 一种制备(2r)-2-丙基辛酸的方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2317019A1 (de) * 1972-04-27 1973-11-08 Upjohn Co Neue 4,5-didehydro-prostaglandine
JPH0672123B2 (ja) 1986-08-21 1994-09-14 セントラル硝子株式会社 トリフルオロメチル基を有するシクロヘキサンカルボン酸の製造方法
JP2868183B2 (ja) * 1988-02-29 1999-03-10 株式式社三和化学研究所 光学活性を有する4−オキソ−1−ベンゾピラン−2−カルボン酸誘導体の製法、その合成用中間体並びに該中間体の製法
EP0632008B1 (en) 1993-06-01 1998-02-04 Ono Pharmaceutical Co., Ltd. Pentanoic acid derivatives
JP3032447B2 (ja) * 1995-04-24 2000-04-17 小野薬品工業株式会社 光学活性な2−プロピルオクタン酸の製造方法
JP3084345B2 (ja) * 1995-04-26 2000-09-04 小野薬品工業株式会社 光学活性な2−プロピルオクタン酸の製造方法
TW509672B (en) 1998-05-12 2002-11-11 Ono Pharmaceutical Co Novel intermediate compounds and processes for the production of optical active octanoic acid derivatives
TWI268921B (en) * 1999-02-18 2006-12-21 Ono Pharmaceutical Co A process for preparing (2R)-2-propyloctanoic acid
US7820715B2 (en) * 2004-04-28 2010-10-26 Ono Pharmaceutical Co., Ltd. Crystal comprising (2R)-2-propyloctanoic acid and amine

Also Published As

Publication number Publication date
CA2364308A1 (en) 2000-08-24
NO20013971D0 (no) 2001-08-15
TWI268921B (en) 2006-12-21
CN100430364C (zh) 2008-11-05
CN1341091A (zh) 2002-03-20
EP1721882A1 (en) 2006-11-15
DE60034316D1 (de) 2007-05-24
ATE359256T1 (de) 2007-05-15
KR100666423B1 (ko) 2007-01-11
ES2283287T3 (es) 2007-11-01
RU2297406C2 (ru) 2007-04-20
NZ513569A (en) 2003-01-31
RU2001125501A (ru) 2004-02-20
CN1183082C (zh) 2005-01-05
AU776927B2 (en) 2004-09-23
MXPA01008241A (es) 2002-08-30
ZA200106500B (en) 2003-02-07
AU2573000A (en) 2000-09-04
JP5343925B2 (ja) 2013-11-13
JP2010248198A (ja) 2010-11-04
CN1636957A (zh) 2005-07-13
DE60034316T2 (de) 2008-01-03
KR20010102161A (ko) 2001-11-15
CN1907938A (zh) 2007-02-07
EP1153910B1 (en) 2007-04-11
CN101100422A (zh) 2008-01-09
US6608221B1 (en) 2003-08-19
WO2000048982A1 (fr) 2000-08-24
EP1153910A1 (en) 2001-11-14
HUP0200358A2 (hu) 2002-05-29
NO20013971L (no) 2001-08-15
JP4752989B2 (ja) 2011-08-17
EP1153910A4 (en) 2002-08-07
HUP0200358A3 (en) 2003-03-28
EP1714956A1 (en) 2006-10-25
CA2364308C (en) 2010-02-02

Similar Documents

Publication Publication Date Title
BR0008261A (pt) Processo para preparação de ácido (2r)-propiloctanóico
ES2143012T3 (es) Composicion catalitica y procedimiento para la desproporcion de olefinas.
BR9806266A (pt) "método de preparação de ácidos de amino carboxìlicos"
ATE92931T1 (de) Fluor- und phosphorhaltige amphiphilische molekuele mit oberflaechenaktiven eigenschaften.
ES2178015T3 (es) Procedimiento de preparacion de isomeros de formoterol opticamente puros.
EP2298301A3 (en) Medicaments for increasing endogenous Erythropoietin (EPO)
BR0213761A (pt) Composições, preparação farmacêutica, artigo industrializado, método de tratamento de mamìferos, célula hospedeira, método para a produção de uma glicoproteìna e uso da composição
NO20071498L (no) Substituerte acylhydroksamsyrer samt fremgangsmate for a redusere TNFa-nivaet
BR9911988A (pt) Composição de catalisador e métodos para sua preparação e uso em um processo de polimerização
BR9909844A (pt) Processo para sintetizar um composto, e, composto.
HRP20030879A2 (en) Pharmaceutically active uridine esters
BR9910573A (pt) Compostos antipicornavirais, preparação e uso dos mesmos
BR0306738A (pt) Processo e aparelho para preparar partìculas cristalinas de uma substância, população de partìculas, e, composição farmacêutica
BR9916187A (pt) Processo para a preparação de 3-alcanoìla e 3-alquilindóis
BR9811839A (pt) Plasma sanguìneo universalmente aplicável
FR2777355B1 (fr) Procede de fixation d'une molecule biologique sur la surface d'un support constitue de silice ou d'oxyde metallique
BR9910399A (pt) Novos intermediários e processos para a preparação de derivados de ácido octanóico opticamente ativo
BR9811643A (pt) Suplementação quìmica de osso
DK492989A (da) Aminopyrrolidinon, farmaceutisk praeparat indeholdende en saadan forbindelse og fremgangsmaade til fremstilling deraf
ES2033370T3 (es) Procedimeinto para preparar cianuro de hidrogeno.
PT1123937E (pt) Substancia gm-95 processo para a sua preparacao e a sua utilizacao
DE59009479D1 (de) Ibuprofen- und S-(+)-Ibuprofen Zubereitungen und Verfahren zu ihrer Herstellung.
DE60125082D1 (de) Verfahren zur Herstellung von optisch aktiven 3,7-Dimethyl-6-octenol und Verfahren zur Herstellung von Zwischenprodukt dafür
BR0011111A (pt) Processos para a preparação de 1,3,5-ciclo-hexanotrionas 2,2,4,4- tetrassubstituìdas, para a preparaçãp de ésteres enol silìlicos, composto,uso de ciclobutano-1,3-dionas
BR9902525A (pt) Processo para compostos de ácido pirrolidinil-hidroxâmico

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: ONO PHARMACEUTICAL CO., LTD. (JP)

Free format text: TRANSFERIDO DE: TOKYO KASEI KOGYO CO., LTD.

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8O E 13 DA LPI.

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.